MELA Sciences Names Michael R. Stewart to Board of Directors
August 05, 2014 08:00 ET
|
MELA Sciences
IRVINGTON, N.Y., Aug. 5, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
MELA Sciences to Report Second Quarter 2014 Financial Results on Wednesday, August 13
August 04, 2014 16:01 ET
|
MELA Sciences
IRVINGTON, N.Y., Aug. 4, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
MELA Sciences Regains Compliance With NASDAQ Listing Requirements
July 29, 2014 08:00 ET
|
MELA Sciences
IRVINGTON, N.Y., July 29, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
MELA Sciences Reports the Closing of Its Private Placement
July 25, 2014 19:03 ET
|
MELA Sciences
IRVINGTON, N.Y., July 25, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the United States and the...
MELA Sciences Announces New Study Results Demonstrating Improved Diagnostic Accuracy for Resident Dermatologists When Utilizing MelaFind Predictive Probability Information
July 24, 2014 08:00 ET
|
MELA Sciences
IRVINGTON, N.Y., July 24, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
MELA Sciences Announces $27.3 Million At The Market Private Placement of Preferred Stock, Debentures and Warrants
July 22, 2014 09:00 ET
|
MELA Sciences
IRVINGTON, N.Y., July 22, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
MELA Sciences Begins Insurance Reimbursement Process With Application for New CPT Code for the MelaFind System
July 10, 2014 08:00 ET
|
MELA Sciences
IRVINGTON, N.Y., July 10, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), announced today that it has taken the first step in the process of seeking insurance reimbursement for its...
MELA Sciences Announces Pending One-for-Ten Reverse Stock Split
July 03, 2014 08:00 ET
|
MELA Sciences
IRVINGTON, N.Y., July 3, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
MELA Sciences Initiates First Study to Investigate Real-World Clinical Impact of the MelaFind System on Melanoma Biopsy Decision
June 03, 2014 08:00 ET
|
MELA Sciences
IRVINGTON, N.Y., June 3, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the United States and the...